Tugheonjon 10/16 mg

Adult dose

Candesartan Cilexetil 1. Essential Hypertension - The recommended initial and maintenance dose is 8 to 16 mg orally once daily. - If blood pressure is still insufficiently controlled after 4 weeks of administration of 16 mg once daily, the dose may be increased to a maximum of 32 mg once daily. - Patients with reduced effective blood volume and renal impairment should start with an initial dose of 4 mg. - Patients with liver impairment should start with an initial dose of 1 daily.

Child dose

Candesartan Cilexetil - The safety and efficacy in adolescents and children under 18 years old have not been established.

This medication can cause severe damage to the fetus, especially in the second to third trimesters of pregnancy, so it must be discontinued immediately upon confirmation of pregnancy. It should not be used in patients with allergies to this drug or its components, severe liver dysfunction, women who are pregnant or breastfeeding, and those with certain renal diseases, muscle disorders, or hereditary angioedema. Elderly patients, those with compromised liver function, patients with hyperkalemia, and those with heart or kidney diseases should use this medication cautiously, and regular blood tests and monitoring of physical condition during treatment are essential. It may cause muscle pain, muscle weakness, and rarely, severe muscle destruction (rhabdomyolysis); consult a doctor immediately if muscle pain or weakness is experienced. Liver function abnormalities may occur, so liver enzyme levels should be checked before treatment, and liver function tests should be conducted periodically while taking the medication. This drug can interact with several other medications, so patients should inform their doctors or pharmacists if they are taking other drugs, especially potassium-sparing diuretics or certain antibiotics, antifungals, and immunosuppressants. Pregnant or breastfeeding women should not take this medication, and women of childbearing age should use appropriate contraceptive methods. The safety and efficacy of this medication in children have not been established; therefore, it should not be administered. Overdose may result in hypotension, dizziness, rapid heartbeat, etc., and in such cases, seek appropriate medical treatment immediately. Dizziness or fatigue may occur during treatment, so caution is advised when driving or operating machinery. Keep the medication out of the reach of children and store it in its original container to maintain quality.

Serious side effects

Urticaria, angioedema, chest tightness, difficulty breathing, cold sweats, pallor, severe rash, blisters, skin exfoliation, oral/ocular mucosal pain, shortness of breath or difficulty breathing, asthma attack, respiratory abnormalities accompanied by cough and fever, jaundice of the skin or eyes, systemic lethargy, sudden and severe headache, thunderclap headache, seizures, altered consciousness, visual disturbances, paralysis, markedly reduced urine output, severe systemic edema, elevated blood pressure.

Mild side effects

• Headache
• dizziness
• nasopharyngitis
• urticaria
• localized infection
• periodontitis
• fatigue
• inflammation
• foreign body sensation
• itching

This medication should be stored in a tightly sealed container to protect it from air and moisture. It is best to maintain a room temperature between 1 to 30 degrees Celsius. Proper storage will help preserve the efficacy of the medication for a longer period.

Appearance

Yellow, round film-coated tablets

Package unit

30 tablets (10 tablets/PTP x 3)